-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Apparent Biology and the Institute of Biophysics of the Chinese Academy of Sciences signed a RIC-seq technology transfer (patent implementation license) agreement, obtained the authorization to implement RIC-seq technology achievement transformation on a global scale, and provided RIC-seq technical services and RIC for life science research.
What is RIC-seq?
RIC-seq is a world-leading original innovative technology developed by Xue Yuanchao's research group at the Institute of Biophysics, Chinese Academy of Sciences.
Figure 1.
How to apply RIC-seq?
RIC-seq technology has important application value.
In terms of medical research, the system uses RIC-seq technology analysis of gene mutations affect the structure and function of the senior target RNA, revealing the pathogenesis of non-coding region mutations and lay the foundation for clinical diagnosis and treatment of related diseases
The transformation application of RIC-seq technology will further enrich the product line of epibiology in the field of medical epigenetics, and will be carried out together with HiChIP technology (DNA-DNA interaction) and RADICL-seq technology (RNA-DNA interaction) The innovative combination strongly promotes the development of domestic biomedical research to a higher dimension and deeper level, and serves the national "Healthy China" grand strategy
Figure 3.
About Appearance
Guangzhou Epigenetic Biotechnology Co.
And related library building kits
Coming soon
Stay tuned !
references:
Cai Zhaokui 1.
